Latest news

Posts about investor

Bloomberg TV: Jane King interviews co-founder and VP of Research, Dr. Tyler Korman

BioClick - an enzyme engineering game-changer

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant

World Bio Market Insights: eXoZymes appoints Damien Perriman as Chief Commercial Officer

Transcript: eXoZymes 4th quarter and full Year 2024 update from April 2, 2025

eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO

eXoZymes Provides Fourth Quarter and Full Year 2024 Update

eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025

Fox Business: Interview with Chief Market Strategist, Lou Basenese

Fox Business: Interview with CEO Michael Heltzen

Edgardo Rayo, new member of the Board of Directors at eXoZymes Inc.

eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.